SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-15-002759
Filing Date
2015-05-28
Accepted
2015-05-28 17:29:08
Documents
5
Period of Report
2015-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tbuff_8k.htm 8-K 59489
2 ASSET PURCHASE AGREEMENT tbuff_ex1.htm EX-1.1 332124
3 AGENCY AGREEMENT tbuff_ex12.htm EX-1.2 354825
4 PRESS RELEASE tbuff_ex991.htm EX-99.1 28437
5 logo.jpg GRAPHIC 9486
  Complete submission text file 0001354488-15-002759.txt   789519
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 15896481
SIC: 2834 Pharmaceutical Preparations